Company / Gross Profit
BeOne Medicines Ltd. Gross Profit History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$4.7B
FY2025
5-year range
$1.0B / $4.7B
FY2021-FY2025
Trend
+45.3%
vs FY2024
Sector context
#4 of 29
Health Care
What the data says
BeOne Medicines Ltd.'s gross profit of $4.7B is higher than 86% of companies in the Health Care sector (FY2025). Gross Profit has increased for 4 consecutive years, from $1.0B in FY2021 to $4.7B in FY2025.
Based on SEC 10-K filings.
$4.7B in FY2025 with a 3-year CAGR of +60.6%. Top quartile in the Health Care sector.
Improved from $2.1B to $4.7B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +60.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 29This company $4.7B Sector average $3.5B
▼
+35.0% above sector average
Key checks
Key Insights
- BeOne Medicines Ltd.'s gross profit has grown for 4 consecutive years.
- 3-year CAGR of +60.6%, indicating consistent growth.
- In FY2025, gross profit increased 45.3% year-over-year.
- Ranks #4 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.7B | +45.3% |
| FY2024 | $3.2B | +54.7% |
| FY2023 | $2.1B | +84.1% |
| FY2022 | $1.1B | +11.7% |
| FY2021 | $1.0B | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026